Financial Services
Medibank Private Limited(MDBPF)
Live Price
Offline$3.90
+0.00% today
1Y Change
+40.79%
Window
Jun 25, 2025 โ Jun 17, 2026
- Market Cap
- $13.00B
- Revenue Growth
- +6.6%
- EPS Growth
- 0.0%
- Dividend Yield
- 3.9%
Coverage: 253 bars ยท Jun 25, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Medibank Private Limited (MDBPF) is a Financial Services stock with a market cap of $13.00B and listed on OTC. The stock last traded around $3.90 and up 40.8% across the available one-year price window (Jun 25, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of +6.6%, EPS growth of 0.0%, a dividend yield of 3.9%. What stands out right now is revenue +6.6%, EPS 0.0%, free cash flow -54.4% with operating margin 48.7% and ROIC 69.0%. The dividend matters to the case here, with a current yield around 3.9%. Valuation is more restrained than many high-expectation growth names at P/E 28.1 and price/sales 1.5. Stock Foundry combines MDBPF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+6.6% vs +3.4% peer median
Operating Margin
Above sector median
+48.7% vs +4.7% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report came in below the EPS bar
2026 was reported on Feb 18, 2026 with an EPS surprise of -1.6% and a revenue surprise of -0.1%.
The setup is mixed rather than one-directional
Revenue is +6.6% and EPS is 0.0%, while operating margin sits near 48.7%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 26, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Feb 18, 2026 | -1.6% | +0.0% | +0.0% | +0.0% |
2025 Aug 27, 2025 | -49.6% | +0.0% | +0.0% | +0.0% |
2025 Feb 26, 2025 | +18.6% | +0.0% | +0.0% | +0.0% |
Benchmark Edge
MDBPF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
MDBPF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
MDBPF Max Drawdown
-15.76%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for MDBPF and SPY.
Company Overview
Medibank Private Limited
Other OTC
Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also offers health insurance products to overseas visitors and overseas students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth services to government and corporate customers; and distributes travel, life, and pet insurance products. The company underwrites its health insurance products under the Medibank and ahm brands Medibank Private Limited was founded in 1976 and is based in Docklands, Australia.
- Leadership
- David Koczkar
- IPO Date
- Oct 22, 2018
- Employees
- 3.2k
- Street Address
- 720 Bourke Street
- Mailing
- Docklands, VIC, 3008
- Region
- Docklands, VIC, AU
- Reporting Currency
- USD
- Investor Line
- 61 3 8622 5222
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 28.1
- EV/EBITDA
- 18.8
- Price/Sales
- 1.5
- Price/Book
- 5.5
Growth
- Revenue
- +6.6%
- EPS
- 0.0%
- Free Cash Flow
- -54.4%
Profitability
- Gross Margin
- 100.0%
- Operating Margin
- 48.7%
- Net Margin
- 5.3%
- ROE
- 19.8%
- ROIC
- 69.0%
Balance Sheet
- Debt/Equity
- 0.21
- Current Ratio
- โ
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.